Dr. Naeem-Ul-Haq Khan is a dedicated researcher and academic specializing in Chemistry, with a focus on Radiopharmaceuticals. He holds a Ph.D. from GC University Faisalabad, Pakistan, and the University of Melbourne, Australia, where his research addressed radionuclide-labeled probes for diagnosing and treating malignant diseases. With a blend of academic and research expertise, Dr. Khan has contributed significantly to healthcare advancements. His professional journey includes roles as a researcher, postdoctoral fellow, and project leader, showcasing his ability to secure competitive funding and lead impactful studies. Dr. Khan has authored multiple peer-reviewed articles in renowned journals, presented his work at international conferences, and participated in technical workshops, underlining his commitment to continuous learning and research excellence.
Professional Profile
Education
Dr. Naeem-Ul-Haq Khan has an impressive academic background. He completed his Ph.D. in Chemistry, specializing in Radiopharmaceuticals, from GC University Faisalabad and the University of Melbourne in 2020. His dissertation focused on developing radionuclide-labeled probes for cancer diagnosis and therapy. He earned his M.Phil. in Chemistry from the University of Agriculture Faisalabad in 2013 and a Master’s in Chemistry from the University of Gujrat in 2009, both with first-division honors. Dr. Khan also holds a Bachelor’s degree from Punjab University, Lahore, and earlier academic certifications in Physics, Chemistry, and Mathematics with exceptional results. His consistent academic performance underscores his dedication to excellence in education.
Professional Experience
Dr. Khan’s professional career is marked by impactful roles in academia and research. He is currently a researcher in the Department of Chemistry at GC University Faisalabad. He served as a postdoctoral fellow at the National Institute for Biotechnology and Genetic Engineering (NIBGE), where he contributed to radiopharmaceutical innovation. Previously, he worked on a national project at the Pakistan Institute of Nuclear Science and Technology (PINSTECH), focusing on 177Lu-labeled kits for medical applications. Earlier in his career, he served as a College Teaching Intern, enhancing his teaching and mentoring skills. Dr. Khan’s professional journey showcases a blend of research innovation and academic contributions.
Research Interests
Dr. Khan’s research interests lie in the innovative field of radiopharmaceuticals. He focuses on developing radionuclide-labeled compounds for the early diagnosis and treatment of diseases, particularly cancer and drug-resistant infections. His work integrates chemistry, biotechnology, and medical imaging, reflecting his commitment to advancing healthcare solutions. Dr. Khan is also interested in the biological evaluation of radiolabeled molecules, the development of novel diagnostic tools, and exploring advanced oxidation processes. His interdisciplinary approach enables the translation of fundamental chemistry into impactful biomedical applications.
Research Skills
Dr. Khan possesses extensive research skills, including radiopharmaceutical synthesis, radionuclide labeling, and biological evaluations. His expertise encompasses modern analytical techniques, such as spectroscopy, chromatography, and imaging tools, to investigate radiolabeled compounds. He is skilled in designing and conducting advanced experiments in chemistry and biotechnology, with proficiency in handling radioactive materials. Additionally, Dr. Khan is experienced in scientific writing, data analysis, and technical presentations. His participation in workshops on research paper writing and analytical methods demonstrates his commitment to refining his research capabilities.
Awards and Honors
Dr. Naeem-Ul-Haq Khan has earned several prestigious awards and honors throughout his career. He was awarded the IRSIP scholarship by the Higher Education Commission (HEC) of Pakistan for advanced research at the University of Melbourne and Peter MacCallum Cancer Centre. He also secured a PKRs. 2.7 million research grant from the National Institute of Health, Islamabad, to develop radiopharmaceuticals for diagnosing infections caused by resistant pathogens. These achievements highlight his ability to attract competitive funding and contribute to cutting-edge research. His academic and research accomplishments have positioned him as a recognized leader in radiopharmaceutical innovation.
Conclusion
Dr. Naeem-Ul-Haq Khan demonstrates exceptional research abilities and a solid track record in radiopharmaceuticals and chemistry. His academic background, research publications, and funding success make him a strong candidate for the Best Researcher Award. To enhance his candidacy further, focusing on citation impact, innovation, and leadership roles in the research community would be beneficial. Overall, Dr. Khan is a deserving nominee with significant contributions to both fundamental and applied sciences. 🌟
Publication Top Notes
- Decolorization of basic turquoise blue X-GB and basic blue X-GRRL by the Fenton’s process and its kinetics
Authors: NUH Khan, HN Bhatti, M Iqbal, A Nazir
Published in: Zeitschrift für Physikalische Chemie 233 (3), 361-373
Year: 2019
Citations: 73
- Antioxidants: Natural antibiotics
Authors: SAR Naqvi, S Nadeem, S Komal, SAA Naqvi, MS Mubarik, SY Qureshi, et al.
Published in: Antioxidants
Year: 2019
Citations: 48
- Kinetic study of degradation of basic turquoise blue X-GB and basic blue X-GRRL using advanced oxidation process
Authors: NUH Khan, HN Bhatti, M Iqbal, A Nazir, H Ain
Published in: Zeitschrift für Physikalische Chemie 234 (11-12), 1803-1817
Year: 2020
Citations: 21
- Assessment of the nutritional status of bottle-fed infants and the prevalence of infections, allergy, and diarrhea among bottle-fed infants and its comparison with exclusively …
Authors: Z Hussain, N Khan
Published in: J Pediatr Neonatal Care 6 (4), 00249
Year: 2017
Citations: 14
- Technetium-99m labeled Ibuprofen: Development and biological evaluation using sterile inflammation induced animal models
Authors: NUH Khan, SAR Naqvi, H Sohail, S Roohi, MA Jamal
Published in: Molecular Biology Reports 46, 3093-3100
Year: 2019
Citations: 11
- Technetium‐99m radiolabeling and biological study of epirubicin for in vivo imaging of multi‐drug‐resistant Staphylococcus aureus infections via single photon …
Authors: NUH Khan, SAR Naqvi, S Roohi, TA Sherazi, ZA Khan, AF Zahoor
Published in: Chemical Biology & Drug Design 93 (2), 154-162
Year: 2019
Citations: 11
- Development of an efficient callus-derived regeneration system for garlic (Allium sativum L.) from root explant
Authors: N Khan, MF Chaudhary, AM Abbasi, SA Khan, A Nazir, GM Shah
Published in: Journal of Plant Breeding and Agriculture 1 (1), 1-12
Year: 2017
Citations: 10
- The role of ethrel in plant growth and development under different environmental conditions
Authors: M Bhat, M Mir, N Khan, NA Lonr, KA Bhat, SM Razui, S Hayat, WA Payne, et al.
Published in: International Journal of Current Research 4, 4-13
Year: 2010
Citations: 7
- Facile one-step synthesis of gold nanoparticles using Viscum album and evaluation of their antibacterial potential
Authors: M Ishaq, M Numan, U Zeb, F Cui, S Shad, SA Hayat, A Azizullah, I Uddin, et al.
Published in: Functional Plant Biology 50 (11), 955-964
Year: 2023
Citations: 3
- Enzymatic degradation study of 111 In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging …
Authors: SAR Naqvi, M Yameen, Z Hussain, S Asim, M Usman, NUH Khan, et al.
Published in: Pakistan Journal of Pharmaceutical Sciences 31 (6 Suppl), 2585-2589
Year: 2018
Citations: 3